Effect of tofacitinib on cardiovascular events and all-cause mortality in patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis of randomized controlled trials. [electronic resource]
Publication details: Therapeutic advances in musculoskeletal disease 2019Description: 1759720X19895492 p. digitalISSN:- 1759-720X
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.